XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses    
Research and development $ 7,410 $ 8,113
General and administrative 3,459 2,997
Total operating expenses 10,869 11,110
Loss from operations (10,869) (11,110)
Other income, net 574 338
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds (13,336)  
Net loss and comprehensive loss $ (23,631) $ (10,772)
Net loss per share, Basic $ (0.79) $ (0.75)
Net loss per share, Diluted $ (0.79) $ (0.75)
Weighted-average common shares outstanding, Basic 29,989,400 14,285,905
Weighted Average Number of Shares Outstanding, Diluted 29,989,400 14,285,905